-
1
-
-
0027992485
-
Role of arginine in health and in renal disease
-
Reyes A.A., Karl I.E., and Klahr S. Role of arginine in health and in renal disease. Am J Physiol 267 (1994) F331-F346
-
(1994)
Am J Physiol
, vol.267
-
-
Reyes, A.A.1
Karl, I.E.2
Klahr, S.3
-
2
-
-
1442333593
-
Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine
-
Raghavan S.A., and Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res 49 (2004) 397-414
-
(2004)
Pharmacol Res
, vol.49
, pp. 397-414
-
-
Raghavan, S.A.1
Dikshit, M.2
-
3
-
-
4744339386
-
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor
-
Boger R.H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 134 (2004) 2842S-2847S
-
(2004)
J Nutr
, vol.134
-
-
Boger, R.H.1
-
4
-
-
12944250997
-
Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients
-
Lau T., Owen W., Yu Y.M., et al. Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest 105 (2000) 1217-1225
-
(2000)
J Clin Invest
, vol.105
, pp. 1217-1225
-
-
Lau, T.1
Owen, W.2
Yu, Y.M.3
-
5
-
-
0027674693
-
L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats
-
Reyes A.A., Karl I.E., Kissane J., et al. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 4 (1993) 1039-1045
-
(1993)
J Am Soc Nephrol
, vol.4
, pp. 1039-1045
-
-
Reyes, A.A.1
Karl, I.E.2
Kissane, J.3
-
6
-
-
0037376220
-
Arginase inhibition slows the progression of renal failure in rats with renal ablation
-
Sabbatini M., Pisani A., Uccello F., et al. Arginase inhibition slows the progression of renal failure in rats with renal ablation. Am J Physiol Renal Physiol 284 (2003) F680-F687
-
(2003)
Am J Physiol Renal Physiol
, vol.284
-
-
Sabbatini, M.1
Pisani, A.2
Uccello, F.3
-
7
-
-
1842529065
-
Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries
-
Palloshi A., Fragasso G., Piatti P., et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 93 (2004) 933-935
-
(2004)
Am J Cardiol
, vol.93
, pp. 933-935
-
-
Palloshi, A.1
Fragasso, G.2
Piatti, P.3
-
8
-
-
0032812457
-
Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure
-
DeNicola L., Bellizzi V., Minutolo R., et al. Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. Kidney Int 56 (1999) 674-684
-
(1999)
Kidney Int
, vol.56
, pp. 674-684
-
-
DeNicola, L.1
Bellizzi, V.2
Minutolo, R.3
-
9
-
-
4744362273
-
L-arginine and hypertension
-
discussion 2818S-2819S
-
Gokce N. L-arginine and hypertension. J Nutr 134 (2004) 2807S-2811S discussion 2818S-2819S
-
(2004)
J Nutr
, vol.134
-
-
Gokce, N.1
-
10
-
-
4544241576
-
Effect of oral L-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients
-
Lim D.S., Mooradian S.J., Goldberg C.S., et al. Effect of oral L-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients. Am J Cardiol 94 (2004) 828-831
-
(2004)
Am J Cardiol
, vol.94
, pp. 828-831
-
-
Lim, D.S.1
Mooradian, S.J.2
Goldberg, C.S.3
|
